BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31076180)

  • 1. Missed opportunities! End of life decision making and discussions in implantable cardioverter defibrillator recipients.
    Miller JL; Chung ML; Etaee F; Hammash M; Thylén I; Biddle MJ; Elayi SC; Czarapata MM; McEvedy S; Cameron J; Haedtke CA; Ski CF; Thompson DR; Moser DK
    Heart Lung; 2019; 48(4):313-319. PubMed ID: 31076180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared Decision-Making About End-of-Life Care Scenarios Compared Among Implantable Cardioverter Defibrillator Patients: A National Cohort Study.
    Thompson JH; Thylén I; Moser DK
    Circ Heart Fail; 2019 Oct; 12(10):e005619. PubMed ID: 31601115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of the EOL-ICDQ as a measure of experiences, attitudes and knowledge in end-of-life in patients living with an implantable cardioverter defibrillator.
    Thylén I; Wenemark M; Fluur C; Strömberg A; Bolse K; Årestedt K
    Eur J Cardiovasc Nurs; 2014 Apr; 13(2):142-51. PubMed ID: 24298191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.
    Lee MC; Sulmasy DP; Gallo J; Kub J; Hughes MT; Russell S; Kellogg A; Owens SG; Terry P; Nolan MT
    Am J Hosp Palliat Care; 2017 Jul; 34(6):518-523. PubMed ID: 27034436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.
    Kelley AS; Reid MC; Miller DH; Fins JJ; Lachs MS
    Am Heart J; 2009 Apr; 157(4):702-8.e1. PubMed ID: 19332199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of HeartQoL, a core heart disease-specific health-related quality of life questionnaire, in Danish implantable cardioverter defibrillator recipients.
    Zangger G; Zwisler AD; Kikkenborg Berg S; Kristensen MS; Grønset CN; Uddin J; Pedersen SS; Oldridge NB; Thygesen LC
    Eur J Prev Cardiol; 2018 Jan; 25(2):142-149. PubMed ID: 28952795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octo- and nonagenarians' outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study.
    Thylén I; Moser DK; Strömberg A
    BMC Geriatr; 2018 Oct; 18(1):250. PubMed ID: 30342484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillator (ICD) deactivation discussions: Reality versus recommendations.
    Hill L; McIlfatrick S; Taylor BJ; Dixon L; Cole BR; Moser DK; Fitzsimons D
    Eur J Cardiovasc Nurs; 2016 Feb; 15(1):20-9. PubMed ID: 25903823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICD recipients' understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life.
    Strömberg A; Fluur C; Miller J; Chung ML; Moser DK; Thylén I
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):834-42. PubMed ID: 24483943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
    Thylén I; Moser DK; Strömberg A; Dekker RA; Chung ML
    Europace; 2016 Jun; 18(6):828-35. PubMed ID: 26324839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring treatment expectations in patients with an implantable cardioverter-defibrillator using the EXPECT-ICD scale.
    Habibović M; Pedersen SS; van den Broek KC; Denollet J
    Europace; 2014 Jul; 16(7):1022-7. PubMed ID: 24596397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Russo JE
    Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.
    Kapa S; Mueller PS; Hayes DL; Asirvatham SJ
    Mayo Clin Proc; 2010 Nov; 85(11):981-90. PubMed ID: 20843982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; Theuns DA; Bhagwandien RE; van Bruchem-Visser RL; Lokker IE; van der Heide A; Rietjens JA
    Eur J Cardiovasc Nurs; 2019 Aug; 18(6):449-457. PubMed ID: 30995145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
    Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review.
    Palacios-Ceña D; Losa-Iglesias ME; Alvarez-López C; Cachón-Pérez M; Reyes RA; Salvadores-Fuentes P; Fernández-de-Las-Peñas C
    J Adv Nurs; 2011 Dec; 67(12):2537-50. PubMed ID: 21615459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' openness to discussing implantable cardioverter defibrillator deactivation at end of life: a cross-sectional study.
    Lee KS; Oh O; Miller J; Hammash M; Thompson DR; Ski CF; Cameron J; Hwang SY; Moser DK
    Eur J Cardiovasc Nurs; 2022 Oct; 21(7):687-693. PubMed ID: 35018427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of patient and partner quality of life and health outcomes in the first year after an implantable cardioverter defibrillator (ICD).
    Dougherty CM; Fairbanks AM; Eaton LH; Morrison ML; Kim MS; Thompson EA
    J Behav Med; 2016 Feb; 39(1):94-106. PubMed ID: 26345262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.